Integer Holdings Corp. (NYSE: ITGR) plans to build a medical device innovation and manufacturing facility in the Parkmore East area of Galway, Ireland.

Plano, Texas–based Integer said the initial phase of the project will total 60,000 square feet and a $30 million investment over the coming years, with construction scheduled from 2022 to late 2023 and equipment investments continuing for another two or three years.

Integer said it has planning permission for another 87,000 square feet of expansion when needed.

The medical device outsource manufacturer cited increased demand for regional research, development and manufacturing capabilities as well as capacity for catheters and delivery systems. Integer already has an R&D center in Galway and counts the manufacturing facilities in Galway and New Ross, County Wexford, among its 15 global manufacturing sites.

The expansion is expected to add 100 to 200 new jobs in engineering, administration and manufacturing, plus several hundred third-party contractors in the Galway region. Integer said it has around 1,300 employees in Ireland, including 350 in Galway.

“This expansion further demonstrates Integer’s commitment to supporting our customers’ growth strategies,” said Payman Khales, president of Integer’s Cardio and Vascular business, in a news release. “The new Galway facility will allow us to continue our investments in research and development in this important medical device hub. The significant manufacturing space in the same facility will allow a seamless transition of new products from development to manufacturing, which will further enable us to help our customers bring products to market faster — a strategic priority as we advance our vision to enhance the lives of patients around the world.”